Influenza Vaccine Market | 2021 Global Analysis By Size, Growth Insights, Developments, Emerging Technologies, Share, Key Players, Trends, Regional Outlook And Global Industry Forecast To 2027 is latest study published by Fortune Business Insights. The Global Influenza Vaccine market expected to rise at 6.9% CAGR and reach USD 7.60 Billion by 2027. Influenza Vaccine Industry is segmented By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers and Others) and Geography Forecast, 2020-2027.
Get Sample Copy of Global Influenza Vaccine Market Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/influenza-vaccine-market-101896
Key Companies Studied In Report:
GlaxoSmithKline plc., Sanofi S.A, AstraZeneca, Seqirus, BioDiem, Emergent BioSolutions Inc., F. Hoffmann-La Roche Ltd, Sinovac Biotech Ltd and other key market players.
Global Influenza Vaccine Market Highlights:
Influenza, also known as flu, is generally a respiratory illness that occurs due to a viral infection. It is highly contagious and mainly spreads through respiratory droplets. In addition to this, it can pass from one person to another through physical contact and while talking. Owing to their serious implications on health, global healthcare organizations such as the Centers for Disease Control and Prevention (CDC) have recommended certain influenza vaccines such as baloxavir marboxil (Xofluza) to treat the symptoms in patients.
The Influenza Vaccine Market report offers an in-depth analysis of the Influenza Vaccine industry and the demand drivers by highlighting information on several aspects of the market. Prudent Markets addresses all these aspects and provides the latest scoop and detailed eye-opening study on all major & emerging business segments. In addition to this, the report sheds light on the industry developments by key players, which are contributing to the expansion of this industry. The development scope, feasibility study, Influenza Vaccine market concentration, and maturity analysis is elaborated in this report.
Information given in the research report pertains to different technological advancements introduced in recent years, which allows for a meticulous analysis of the industry and offers a more comprehensive understanding to the readers.
The global influenza vaccine market is expected to gain momentum by reaching USD 7.60 billion by 2027 owing to the increasing prevalence of chronic disease and the growing efforts in R&D activities by major companies to develop innovative and effective influenza vaccine treatment during the forecast period.
The outbreak of covid-19 in the global market has made companies uncertain about their future scenario as the prolonged lock-down finds a serious economic slump. The latest survey on COVID-19 Outbreak-Global Influenza Vaccine Market is conducted to provide hidden gems performance analysis. Essential growth factors and study of Basis points [BPS] have been discussed in the following report. Research Report explains a detailed overview of market dynamics, segmentation, product portfolio, business plans, and the latest development in the industry.
The increasing focus on R&D activities to develop a vaccine to contain the widespread effect of the novel coronavirus is driving the demand for immunization across the globe. The COVID-19 pandemic has brought unprecedented changes in the healthcare industry. An increasing demand for the seasonal influenza vaccine to ensure better protection against the deadly pandemic is anticipated to favor the market growth in the near future.
Out research methodology is robust and includes data triangulation based on bottom-up and top-down approaches. We validated the approximate market number with the help of primary research. Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements. At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.
According to the World Health Organization (WHO), seasonal influenza has serious implications for health globally. It is estimated that around 1 billion people are affected by it every year. The increasing prevalence of chronic disease is propelling the manufacturers to develop innovative influenza vaccines. The increasing geriatric population globally is further anticipated to favor the global flu vaccine market during the forecast period. The global healthcare organizations have recommended several licensed vaccines that are being adopted largely to prevent chronic diseases that are propelling the companies to invest in developing innovative vaccines globally. This is expected to bode well for the market growth in the forthcoming years.
It offers figurative estimations for upcoming years on the basis of the recent developments and historic data. For gathering information and estimating revenue for all segments, researchers have used top-down and bottom-up approaches. On the basis of data collected from primary and secondary research and trusted data sources the report will help both existing and new aspirants for Influenza Vaccine market to figure out and study the market’s needs, market size, and competition.
The pediatric segment, based on age group, is expected to showcase an exponential growth. This is attributable to the increasing rate of influenza amongst infants and the younger population that is driving the demand for an efficient influenza vaccine.
- North America (the USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Latin America (Brazil, Mexico and Rest of Latin America)
- Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Among all the regions, North America is expected to hold the highest position in the global flu vaccine market. This dominance is attributable to the presence of established companies such as Emergent BioSolutions, Inc. that are increasing their focus on developing advanced influenza vaccines for therapeutic purposes in countries such as the U.S. The region stood at USD 2.18 billion in 2019.
The market in Asia-Pacific is expected to showcase a significant growth in the forthcoming years. This is ascribable to factors such as the increasing geriatric population and the supportive government initiative to promote this vaccine between 2020 and 2027.
This report focuses on Influenza Vaccine Global Market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Regional analysis is another highly comprehensive part of the research and analysis study of the global market presented in the report. This section sheds light on the sales growth of different regional and country-level markets. For the historical and forecast period to 2027, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global market.
For More Questions, Talk with Influenza Vaccine Industry Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/influenza-vaccine-market-101896
Influenza Vaccine Highlights of the Report:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the Supply Chain Analytics market.
- Product Development/Innovation: Detailed insights on the upcoming technologies, RandD activities, and product launches in the market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Supply Chain Analytics market
Competitive Analysis And Industry News:
Major companies in the global Influenza Vaccine Market are increasingly focusing on research and development activities to create new and innovative products to stay ahead of the competition. Staying on top of market trends & drivers is crucial for decision-makers to hold this emerging opportunity. The study provides information on market trends and development, drivers, capacities, technologies, and the changing investment structure of the Influenza Vaccine Industry.
Key questions answered in the report:
- What will the market growth rate of Influenza Vaccine Market in 2027?
- What are the key factors driving the global Influenza Vaccine Market?
- Who are the key manufacturers in Influenza Vaccine Market space?
- What are the market opportunities, market risk and market overview of the Influenza Vaccine Global market?
- What are sales, revenue, and price analysis of top manufacturers of Influenza Vaccine Global market?
- What are sales, revenue, and price analysis by types and applications of Influenza Vaccine Market?
- What are sales, revenue, and price analysis by regions of Influenza Vaccine market?
Browse More Information on This Report: https://www.fortunebusinessinsights.com/industry-reports/influenza-vaccine-market-101896
Table Of Content:
1 Market Overview
1.1 Influenza Vaccine Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
184.108.40.206 United States Market States and Outlook (2020-2027)
220.127.116.11 Canada Market States and Outlook (2020-2027)
18.104.22.168 Mexico Market States and Outlook (2020-2027)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
22.214.171.124 Germany Market States and Outlook (2020-2027)
126.96.36.199 France Market States and Outlook (2020-2027)
188.8.131.52 UK Market States and Outlook (2020-2027)
184.108.40.206 Russia Market States and Outlook (2020-2027)
220.127.116.11 Italy Market States and Outlook (2020-2027)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
18.104.22.168 China Market States and Outlook (2020-2027)
22.214.171.124 Japan Market States and Outlook (2020-2027)
126.96.36.199 Korea Market States and Outlook (2020-2027)
188.8.131.52 India Market States and Outlook (2020-2027)
184.108.40.206 Southeast Asia Market States and Outlook (2020-2027)
1.4.4 South America, Middle East and Africa
220.127.116.11 Brazil Market States and Outlook (2020-2027)
18.104.22.168 Egypt Market States and Outlook (2020-2027)
22.214.171.124 Saudi Arabia Market States and Outlook (2020-2027)
126.96.36.199 South Africa Market States and Outlook (2020-2027)
188.8.131.52 Turkey Market States and Outlook (2020-2027)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
3 Global Influenza Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Influenza Vaccine Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Influenza Vaccine Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Influenza Vaccine Manufacturer Market Share in 2018
3.3.2 Top 6 Influenza Vaccine Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Influenza Vaccine Market Analysis by Regions
4.1 Global Influenza Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Influenza Vaccine Sales and Market Share by Regions (2020-2027)
4.1.2 Global Influenza Vaccine Revenue and Market Share by Regions (2020-2027)
4.2 North America Influenza Vaccine Sales and Growth Rate (2020-2027)
4.3 Europe Influenza Vaccine Sales and Growth Rate (2020-2027)
4.4 Asia-Pacific Influenza Vaccine Sales and Growth Rate (2020-2027)
4.5 South America Influenza Vaccine Sales and Growth Rate (2020-2027)
4.6 Middle East and Africa Influenza Vaccine Sales and Growth Rate (2020-2027)
5 North America Influenza Vaccine by Country
5.1 North America Influenza Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Influenza Vaccine Sales and Market Share by Country (2020-2027)
5.1.2 North America Influenza Vaccine Revenue and Market Share by Country (2020-2027)
5.2 United States Influenza Vaccine Sales and Growth Rate (2020-2027)
5.3 Canada Influenza Vaccine Sales and Growth Rate (2020-2027)
5.4 Mexico Influenza Vaccine Sales and Growth Rate (2020-2027)
8 South America Influenza Vaccine by Country
8.1 South America Influenza Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Influenza Vaccine Sales and Market Share by Country (2020-2027)
8.1.2 South America Influenza Vaccine Revenue and Market Share by Country (2020-2027)
8.2 Brazil Influenza Vaccine Sales and Growth Rate (2020-2027)
8.3 Argentina Influenza Vaccine Sales and Growth Rate (2020-2027)
8.4 Colombia Influenza Vaccine Sales and Growth Rate (2020-2027)
9 Middle East and Africa Influenza Vaccine by Countries
9.1 Middle East and Africa Influenza Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Influenza Vaccine Sales and Market Share by Country (2020-2027)
9.1.2 Middle East and Africa Influenza Vaccine Revenue and Market Share by Country (2020-2027)
9.2 Saudi Arabia Influenza Vaccine Sales and Growth Rate (2020-2027)
9.3 Turkey Influenza Vaccine Sales and Growth Rate (2020-2027)
9.4 Egypt Influenza Vaccine Sales and Growth Rate (2020-2027)
9.5 Nigeria Influenza Vaccine Sales and Growth Rate (2020-2027)
10 Influenza Vaccine Market In Developing Countries
11 South America Influenza Vaccine Market Analysis by Countries
12 Competitive Landscape
13 Industry Outlook
13.1 Market Driver Analysis
13.1.2 Market Restraints Analysis
13.1.3 Market Trends Analysis
13.2 Merger, Acquisition and New Investment
13.3 News of Product Release
14 Global Influenza Vaccine Market Forecast
15 New Project Feasibility Analysis
15.1 Industry Barriers and New Entrants SWOT Analysis
15.1.1 Porter’s Five Forces Analysis
15.1.2 New Entrants SWOT Analysis
15.2 Analysis and Suggestions on New Project Investment
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
411045, Maharashtra, India.
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245